Antibodies to GT1a ganglioside in patients with Guillain-Barre syndrome

Journal of Neuroimmunology

Volumn 82, Issue 2, 1998, Pages 160-167

  Ilyas, A A ^a   Cook, S D ^a   Mithen, F A ^b   Taki, T ^c   Kasama, T ^c   Handa, S ^c   Hamasaki, H ^c   Singhal, B S ^d   Li, S C ^e   Li, Y T ^e  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d BOMBAY HOSPITAL   (India)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; GT1a ganglioside; Guillain Barre syndrome; Miller Fisher syndrome

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GT 1A; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CATTLE; CLINICAL FEATURE; CONTROLLED STUDY; CRANIAL NEUROPATHY; DEMYELINATING NEUROPATHY; DYSPHAGIA; EXTRAOCULAR MUSCLE; FACIAL NERVE DISEASE; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; SCHOOL CHILD; SUBCLAVIAN STEAL SYNDROME;

ADULT; AGED; ANIMALS; ANTIBODIES; CATTLE; CHILD; CHROMATOGRAPHY, THIN LAYER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MILLER FISHER SYNDROME; NERVOUS SYSTEM DISEASES; PERIPHERAL NERVES; POLYRADICULONEUROPATHY; REFERENCE VALUES;

EID: 0031895202     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00197-5     Document Type: Article

References (47)

1. Ando S., Yu R.K. Isolation and characterization of a novel trisialoganglioside, GT1a, from human brain. J. Biol. Chem. 18:1977;6247-6250.
2. Asbury A.K., Arnason B.G.W., Karp H.R., McFarlin D.E. Criteria for the diagnosis of Guillain-Barré syndrome. Ann. Neurol. 3:1978;565-566.
3. Chiba A., Kusunoki S., Shimizu T., Kanazawa I. Serum IgG antibody to GQ1b as a possible marker of Miller-Fisher syndrome. Ann. Neurol. 31:1992;677-679.
4. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: Clinical and histochemical studies. Neurology. 43:1993;1911-1917.
5. Cook, S.D., Dowling, P.C., Blumberg, B.M., 1987. Infection and autoimmunity in the Guillain-Barré syndrome. In: Aarli, J.A., Behan, W.M.H., Behan, P.O. (Eds.), Clinical Neuroimmunology. Blackwell Scientific Publications, Oxford, pp. 224-225.
6. Fredman P., Vedeler C.A., Nyland H., Aarli J.A., Svennerholm L. Antibodies in sera from patients with inflammatory demyelinating polyradiculopathy react with ganglioside LM1 and sulfatide of peripheral myelin. J. Neurol. 238:1991;75-79.
7. Gregson N.A., Koblar S., Hughes R.A.C. Antibodies to gangliosides in patients with Guillain-Barré syndrome: Specificity and relationship to clinical features. Q. J. Med. 86:1993;111-117.
8. Hirabayashi Y., Suzuki T., Suzuki Y., Taki T., Matzumoto M., Higashi H., Kato S. A new method for purification of anti-glycosphingolipid antibody. Avian anti-hematoside (NeuGc) antibody. J. Biochem. 94:1983;327-330.
9. Hirabayashi Y., Nako T., Matsumoto M. Improved method for large scale purification of brain gangliosides by Q-sepharose column chromatography. Immunological detection of C-series polysialoganliosides in adult bovine brains. J. Chromatogr. 445:1988;377-484.
10. Hughes, R.A.C., 1990. The Guillain-Barré Syndrome. Springer-Verlag, Heidelberg.
11. Hughes R.A.C., Newsom-Davis J., Perkins G.D., Pierce J.M. Controlled trial of prednisolone in acute polyneuropathy. Lancet. 2:1978;750-753.
12. Ilyas A.A., Quarles R.H., McIntosh T.D., Dobersen M.J., Dalakas M.C., Trapp B.D., Brady R.O. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. Proc. Natl. Acad. Sci. USA. 81:1984;1225-1229.
13. Ilyas A.A., Quarles R.H., Dalakas M.C., Brady R.O. Polyneuropathy with monoclonal gammopathy: Glycolipids are frequently antigens for IgM paraproteins. Proc. Natl. Acad. Sci. USA. 82:1985;6697-6700.
14. Ilyas A.A., Li S.-C., Chou D.K.H., Li Y.T., Jungalwala F.B., Dalakas M.C., Quarles R.H. Gangliosides GM2, IV GalNAcGM1b, and IVGalNAcGD1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. J. Biol. Chem. 263:1988;4369-4373.
15. Ilyas A.A., Willison H.J., Dalakas M.C., Whitaker J.N., Quarles R.H. Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy. J. Neurochem. 51:1988;851-858.
16. Ilyas A.A., Willison H.J., Quarles R.H., Jungalwala F.B., Cornblath D.R., Trapp B.D., Griffin D.E., Griffin J.W., McKhann G.M. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann. Neurol. 23:1988;440-447.
17. Ilyas A.A., Miten F.A., Chen Z.W., Cook S.D. Search for antibodies to neutral glycolipids in Guillain-Barré syndrome. J. Neurol. Sci. 102:1991;67-75.
18. Ilyas A.A., Mithen F.A., Dalakas M.C., Wargo M., Chen Z.W., Bielory L., Cook S.D. Antibodies to sulfated glycolipids in Guillain-Barré syndrome. J. Neurol. Sci. 105:1991;108-117.
19. Ilyas A.A., Mithen F.A., Chen Z.W., Cook S.D. Anti-GM1 IgA antibodies in Guillain-Barré syndrome. J. Neuroimmunol. 36:1992;69-76.
20. Ilyas A.A., Mithen F.A., Dalakas M.C., Chen Z.W., Cook S.D. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 107:1992;111-121.
21. Ilyas A.A., Cook S.D., Mithen F.A., Singhal B., Taki T., Li Y.-T. Antibodies to GT1a gangliosides in patients with Guillain-Barré syndrome. Neurology. 48:1997;A53.
22. Kusunoki S., Chiba A., Kon K., Ando S., Arisawa K., Tate A., Kanazawa I. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann. Neurol. 35:1994;570-576.
23. Kusunoki S., Iwamori M., Chiba A., Hitoshi S., Arita M., Kanazawa I. GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome. Ann. Neurol. 47:1996;237-242.
24. Kusunoki S., Shimuzu J., Chiba A., Ugawa Y., Hitoshi S., Kanazawa I. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann. Neurol. 39:1996;424-431.
25. Mishu B., Ilyas A.A., Koski C.L., Vriesendorp F., Cook S.D., Mithen F.A., Blaser M.J. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann. Intern. Med. 18:1993;947-953.
26. Mithen F.A., Ilyas A.A., Birchem R., Cook S.D. Effects of Guillain-Barre' sera containing antibodies against glycolipids in cultures of rat Schwann cells and sensory neurons. J. Neurol. Sci. 112:1992;223-232.
27. Mizoguchi K., Hase A., Obi T., Matsuoka H., Takatsu M., Nishimura Y., Irie F., Seyma Y., Hirabayashi Y. Two species of anti-ganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry. 57:1994;1121-1123.
28. Nobile-Orazio E., Carpo M., Meucci N., Grassi M.P., Capitani E., Sciacco M., Mangoni A., Scarlato G. Guillain-Barré associated antibodies with high titers of anti-GM1 antibodies. J. Neurol. Sci. 109:1992;200-206.
29. O'Leary C.P., Veitch J., Durward W.F., Thomas A.M., Rees J.H., Willison H.J. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J. Neurol. Neurosurg. Psychiatry. 61:1996;649-651.
30. Quarles R.H., Ilyas A.A., Willison H.J. Antibodies to glycolipids in demyelinating disease of the human peripheral nervous system. Chem. Phys. Lipids. 42:1986;235-248.
31. Roberts M., Willison H., Vincent A., Newsom-Davis J. Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet. 343:1994;454-455.
32. Roberts M., Willison H., Vincent A., Newsom-Davis J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann. Neurol. 38:1995;111-118.
33. Ropper, A.H., Wijdicks, E.F.M., Truax, B.T., 1991. Guillain-Barré Syndrome. F. Davis Company, Philadelphia.
34. Speed B.R., Kaldor J., Watson J., Newtom-John H., Tee W., Noonan D., Dwyer B.W. Campylobacter jejuni/Campylobacter coli-associated Guillain-Barré syndrome. Immunoblot confirmation of the serological response. Med. J. Austr. 147:1987;13-16.
35. Taki T., Rokukawa C., Kasama T., Handa S. Human hepatoma gagliosides: Occurrence of a novel I-type glycolipid with NeuAc 2-6 structure. Cancer Res. 52:1992;4805-4811.
36. Taki T., Handa S., Ishikawa D. Blotting of glycolipids and phospholipids from high performnce thin-layer chromatogram to a polyvinylidine difluoride membrane. Anal. Biochem. 221:1994;312-316.
37. Taki T., Ishikawa D., Handa S., Kasama T. Direct mass spectrometric analysis of glycosphingolipid transferred to a polyvinylidene difluoride membrane by thin-layer chromatography blotting. Anal. Biochem. 225:1995;24-27.
38. + currents in isolated rat myelinated nerve fibers. Ann. Neurol. 37:1995;436-442.
39. Thomas F.P., Trojaborg W., Nagy C., Santoro M., Sadiq S.A., Latov N., Hays H.A. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the node of Ranvier. Acta Neuropathol. 82:1991;378-383.
40. Ueno K., Ando S., Yu R.K. Gangliosides of human, cat and rabbit spinal cords and cord myelin. J. Lipid Res. 19:1978;863-871.
41. Van den Berg L.H., Marrink J., De Jager X., De Jong H.G., van Imhoff G.W., Latov N., Sadiq S.A. Anti-GM1 antibodies in patients with Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry. 55:1992;8-11.
42. Vriesendorp F.J., Mishu B., Blaser M.J., Koski C.L. Serum antibodies to GM1, GD1b, peripheral nerve myelin and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: Correlation and prognosis. Ann. Neurol. 34:1993;130-135.
43. Walsh F.S., Cronin M., Kobler S., Doherty P., Winer J., Leon A., Hughes R.A.C. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J. Neuroimmunol. 34:1991;43-51.
44. Warren L. The thiobarbituric acid assay of sialic acid. J. Biol. Chem. 234:1959;1971-1975.
45. Willison H.J., Veitch J., Patterson G., Kennedy P.G. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiatry. 56:1993;204-206.
46. Yuki N., Yoshino H., Sato S., Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology. 40:1990;1900-1902.
47. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Handa S., Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside like structure. J. Exp. Med. 178:1993;1771-1775.